Table 1 Sensitivity analysis
PCI Day 0-1 | PCI Day 2-29 | |||
|---|---|---|---|---|
Landmark analyses | Log rank | P-value | Log rank | P-value |
Day 91-180 | ||||
Death | 0.11 | 0.002 | ||
Recurrent MI | 0.17 | 0.07 | ||
Combined | 0.06 | 0.007 | ||
Day 181-540 | ||||
Death | 0.25 | 0.001 | ||
Recurrent MI | 0.33 | 0.99 | ||
Combined | 0.65 | 0.1 | ||
Cox Proportional Hazards Model | HR (CI)* | P-value | HR (CI)* | P-value |
Day 91-180 | ||||
Death | ||||
No clopidogrel | 1.00 | 1.00 | ||
Clopidogrel | 0.49 (0.23-0.97) | 0.04 | 0.28 (0.12-0.64) | 0.003 |
Recurrent MI | ||||
No clopidogrel | 1.00 | 1.00 | ||
Clopidogrel | 0.71 (0.42-1.19) | 0.19 | 0.75 (0.40-1.38) | 0.35 |
Combined | ||||
No clopidogrel | 1.00 | 1.00 | ||
Clopidogrel | 0.66 (0.43-1.02) | 0.06 | 0.62 (0.37-1.04) | 0.07 |
Day 181-540 | ||||
Death | ||||
No clopidogrel | 1.00 | 1.00 | ||
Clopidogrel | 0.83 (0.55-1.23) | 0.34 | 0.55 (0.35-0.86) | 0.01 |
Recurrent MI | ||||
No clopidogrel | 1.00 | 1.00 | ||
Clopidogrel | 1.17 (0.76-1.81) | 0.48 | 0.79 (0.50-1.24) | 0.3 |
Combined | ||||
No clopidogrel | 1.00 | 1.00 | ||
Clopidogrel | 0.92 (0.68-1.25) | 0.58 | 0.73 (0.53-1.02) | 0.07 |